The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Kolbanov K.I.

P.A. Herzen Moscow Oncology Research Institute - Branch National Medical Radiology Research Center of the Ministry of Health of the Russia

Ryabov A.B.

Hertsen Moscow Oncology Research Institute

Pikin O.V.

Hertsen Moscow Oncology Research Institute

Glushko V.A.

Herzen Research Institute of Oncology

International TNM classification and the diagnosis of lung cancer

Authors:

Kolbanov K.I., Ryabov A.B., Pikin O.V., Glushko V.A.

More about the authors

Journal: P.A. Herzen Journal of Oncology. 2022;11(3): 65‑74

DOI: 10.17116/onkolog20221103165

Read: 12672 times

Download PDF (RU)
Contact the author
Table of contents

INTERNATIONAL TNM CLASSIFICATION AND THE DIAGNOSIS OF LUNG CANCER
INTERNATIONAL TNM CLASSIFICATION AND THE DIAGNOSIS OF LUNG CANCER

To cite this article:

Kolbanov KI, Ryabov AB, Pikin OV, Glushko VA. International TNM classification and the diagnosis of lung cancer. P.A. Herzen Journal of Oncology. 2022;11(3):65‑74. (In Russ.)
https://doi.org/10.17116/onkolog20221103165

Подписка 2026 Онкология. Журнал им. П.А. Герцена (P.A. Herzen Journal of Oncology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Video-assisted mediastinal lymphadenectomy in the treatment stra­tegy of patients with non-small cell lung cancer. P.A. Herzen Journal of Onco­logy. 2025;(5):13-18
Exosomal non-coding rnas as pote­ntial biomarkers in the diagnosis and prognosis of lung cancer. Review. Labo­ratory Service. 2024;(3):42-49
The first thousand of VATS anatomical lung rese­ctions at the Herzen Moscow Onco­logy Research Institute. Piro­gov Russian Journal of Surgery. 2025;(6):7-18
Prognostic model and calculator for asse­ssing the risk of prolonged pleural effu­sion after lobe­ctomy. Piro­gov Russian Journal of Surgery. 2025;(6):26-34
Fibrosing inte­rstitial lung disease as a risk factor for lung cancer: a review of the lite­rature and clinical case report. Journal of Respiratory Medi­cine. 2025;(2):51-59
Modern classifications of lumbosacral transitional vertebrae in patients with lumbodynia. Russian Journal of Pain. 2025;(2):76-82
Survival of patients with mali­gnant lung neoplasms in the Tomsk region (2013—2022). Russian Journal of Preventive Medi­cine. 2025;(7):43-49
Morphological examination of surgical mate­rial of primary lung cancer after neoadjuvant therapy: reco­mmendations and lite­rature review. Russian Journal of Archive of Pathology. 2025;(4):40-46
Features of lung cancer carcinogenesis invo­lving cancer stem cells in COVID-19. Effe­cts of photodynamic therapy in the treatment of cancer and COVID-19. Russian Journal of Archive of Pathology. 2025;(5):65-73
Pulmonary artery surgery in thoracic onco­logy. Piro­gov Russian Journal of Surgery. 2025;(10):24-30
Abstract:

The paper summarizes the existing modern classifications used in clinical oncology in the diagnosis of lung cancer and at the stage of treatment in patients with this pathology. It characterizes the basic principles of applying the clinical, anatomical, and morphological classification. The aspects of the International classification according to the TNM system and lung cancer staging are analyzed in detail. The features of applying the clinical, post-therapeutic, pathological, and anatomical classification are discussed, by taking into account the criteria T, N, and M, as well as the gradation of a residual tumor after surgical and medical treatment. The paper presents options for making a cancer diagnosis in patients with lung cancer, by considering the main classifications, treatment, the stages of diagnosis and follow-up.

Keywords:

lung cancer
classifications
international TNM classification of malignant tumors
making a diagnosis

Authors:

Kolbanov K.I.

P.A. Herzen Moscow Oncology Research Institute - Branch National Medical Radiology Research Center of the Ministry of Health of the Russia

Ryabov A.B.

Hertsen Moscow Oncology Research Institute

Pikin O.V.

Hertsen Moscow Oncology Research Institute

Glushko V.A.

Herzen Research Institute of Oncology

Received:

03.09.2021

Accepted:

25.10.2021

Close metadata

References:

  1. Classification of lung cancer. Edition Nihon Haigan Gakkai, Kanehara & Company; 2000:128. 
  2. International Association for the Study of Lung Cancer. Staging manual in thoracic oncology. USA: Editorial Rx Press Orange Park; 2009.
  3. Savitsky AI. Lung cancer. M.: Medgiz; 1957:273. (In Russ.).
  4. Trakhtenberg AKh, Kolbanov KI. Lung cancer. M.: GEOTAR-Media; 2014:158. (In Russ.).
  5. Travis WD, Brambillla E, Burke AP, Mark A, Nicholson AG. WHO classification of tumours of the lung, pleura, thymus and heart. Lyon: IARC; 2015. https://doi.org/10.1097/JTO.0000000000000663
  6. Beasley MB, Brambilla E, Travis WD. The 2004 World Health Organization classification of lung tumors. Semin Roentgenol. 2005;40(2):90-97.  https://doi.org/10.1053/j.ro.2005.01.001
  7. Borczuk AC. Prognostic considerations of the new World Health Organization classification of lung adenocarcinoma. Eur Respir Rev. 2016;25:364-371.  https://doi.org/10.1183/16000617.0089-2016
  8. Sobin LH, Gospodarowicz MK, Wittekind Ch, eds. TNM Classification of malignant tumors. Translated from English. M.: Logosfera; 2011:275. 
  9. Rami-Porta R, Asamura H, Brierley J, Goldstraw PJ. Staging, tumor profile, and prognostic groups in lung cancer or the new tower of babel. Thorac Oncol. 2016;11(8):1201-1203. https://doi.org/10.1016/j.jtho.2016.04.019
  10. American Joint Committee on Cancer. AJCC cancer staging manual. 8th ed. Chicago: Springer; 2017:1024.
  11. Trakhtenberg AKh, Kolbanov KI. Controversial issues of the International classification according to the TNM system and aspects of its improvement. In: Trakhtenberg AKh, Chissov VI. Lung cancer. M.: GEOTAR-Media; 2009:113-119. 
  12. Grunenwald DH. Surgery for advanced stage lung cancer. Semin Surg Oncol. 2000;18(2):137-142. https://doi.org/10.1002/(sici)1098-2388(200003)18:2<137::aid-ssu7>3.0.co;2-a "> 3.0.co;2-a" target="_blank">https://doi.org/10.1002/(sici)1098-2388(200003)18:2<137::aid-ssu7>3.0.co;2-a
  13. Kolbanov KI, Trakhtenberg AKh, Frank GA, Zavalishina LE, Boyko AV, Pikin OV, Glushko VA. Prognostic factors, results of surgical and combination treatments in patients with different morphological types of non-small cell lung carcinoma. P.A. Herzen Journal of Oncology. 2013;2(3):11-16. (In Russ.).
  14. Dai H, Hui Z, Ji W, Liang J, Lu J, et al. Postoperative radiotherapy for resected pathological stage IIIA-N2 non-small cell lung cancer: A retrospective study of 221 cases from a single institution. Oncologist. 2011;16(5):641-650.  https://doi.org/10.1634/theoncologist.2010-0343
  15. Hishida T, Yoshida J, Ohe Y, Aokage K, Ishii G, Nagai K. Surgical outcomes after initial surgery for clinical single-station N2 non-small-cell lung cancer. Jpn J Clin Oncol. 2014;44(1):85-92.  https://doi.org/10.1093/jjco/hyt164
  16. Asamura H, Chansky K, Crowley J, et al. The International Association for the Study of Lang Cancer stadging project: proposals for the revision of the N descriptjrs in the forthocoming 8th edition of the TNM classification for lung cancer. J Thorac Oncol. 2015;10(12):1675-1684. https://doi.org/10.1097/JTO.0000000000000678
  17. Wittekind Ch, Brierley JD, Lee A, van Eycken E, eds. UICC. TNM Supplement: a commentary on uniform use. Wiley Blackwell; 2019:328. 
  18. Chissov VI, Trakhtenberg AKh. Primary-multiple malignant tumors. M.: Meditsina; 2000. (In Russ.).
  19. Brierley JD, Gospodarowicz MK,Wittekind Ch, eds. TNM Classification of malignant tumors. Translated from English and scientific editing Dubova EA, Pavlov KA. M.: Logosfera; 2018. (In Russ.).
  20. Wittekind C, Compton C, Quirke P, Nagtegaal I, Merkel S, Hermanek P, Sobin LH. A uniform residual tumour (R) classification. Integration of the R classification and the circumferential margin status. Cancer. 2009;115:3483-3488. https://doi.org/10.1002/cncr.24320.
  21. Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: Evolving considerations for PET response Cciteria in solid tumors. J Nucl Med. 2009;50(Suppl 1):122-150.  https://doi.org/10.2967/jnumed.108.057307
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.